- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 307/66 - Atomes d'azote
Détention brevets de la classe C07D 307/66
Brevets de cette classe: 104
Historique des publications depuis 10 ans
|
7
|
10
|
10
|
7
|
7
|
11
|
4
|
7
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Midwestern University | 41 |
7 |
| Ottawa Hospital Research Institute | 115 |
5 |
| University of Ottawa | 240 |
5 |
| The University of Sydney | 640 |
4 |
| Anji Pharmaceuticals Inc. | 31 |
4 |
| Viotika Life Sciences Inc. | 6 |
4 |
| FUJIFILM Corporation | 30543 |
3 |
| Nodthera Limited | 43 |
3 |
| Perenna Pharmaceuticals, Inc. | 4 |
3 |
| Biofront Ltd. (Cayman) | 17 |
3 |
| Elara Pharmaceuticals GmbH | 9 |
2 |
| European Molecular Biology Laboratory (embl) | 22 |
2 |
| Neuropharma, S.A. | 3 |
2 |
| Nihon Nohyaku Co., Ltd. | 325 |
2 |
| The Regents of the University of Colorado, a body corporate | 2812 |
2 |
| Rhode Island Hospital | 204 |
2 |
| Ottawa Hospital Research Institute and University of Ottawa | 2 |
2 |
| Samsung Electronics Co., Ltd. | 158156 |
1 |
| Boehringer Ingelheim International GmbH | 4487 |
1 |
| Merck Patent GmbH | 5731 |
1 |
| Autres propriétaires | 46 |